Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

China flag China · Delayed Price · Currency is CNY
3.610
+0.020 (0.56%)
Mar 10, 2026, 12:54 PM CST
4.64%
Market Cap 10.78B
Revenue (ttm) 5.49B
Net Income (ttm) -66.13M
Shares Out 3.00B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend 0.03 (0.84%)
Ex-Dividend Date Jun 24, 2025
Volume 17,977,214
Average Volume 46,017,554
Open 3.520
Previous Close 3.590
Day's Range 3.520 - 3.610
52-Week Range 3.080 - 4.490
Beta 0.10
RSI 45.65
Earnings Date Apr 21, 2026

About SHE:300026

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 ... [Read more]

Sector Healthcare
Founded 1996
Employees 5,297
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300026
Full Company Profile

Financial Performance

In 2024, SHE:300026's revenue was 5.78 billion, a decrease of -5.34% compared to the previous year's 6.11 billion. Earnings were 21.47 million, a decrease of -95.76%.

Financial Statements

News

There is no news available yet.